+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KILITCH

Kilitch Drugs(I) Share Price

 

 

Kilitch Drugs(I) live price: ₹189.03. It opened at ₹182 vs previous close ₹182; intraday high/low: ₹192/₹181. The 50 & 200 DMA stand at ₹166.92/₹169.12.

Kilitch Drugs(I) Performance

  • Today's Low
  • ₹181
  • Today's High
  • ₹192
  • 52 Week Low
  • ₹117
  • 52 Week High
  • ₹250
  • Open Price₹182
  • Previous Close₹182
  • Volume126,680
  • 50 DMA₹166.92
  • 100 DMA₹165.05
  • 200 DMA₹169.12

Kilitch Drugs(I) Chart

Investment Returns

  • Over 1 Month + 19.72%
  • Over 3 Month + 18.92%
  • Over 6 Month + 10.66%
  • Over 1 Year -15.09%

Smart Investing Starts Here Start SIP with Kilitch Drugs(I) for Steady Growth!

Invest Now

Kilitch Drugs(I) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.9
  • PEG Ratio
  • 1.5
  • Market Cap Cr
  • 661
  • P/B Ratio
  • 2.4
  • Average True Range
  • 11.07
  • EPS
  • 8.63
  • Dividend Yield
  • 0
  • MACD Signal
  • 6.46
  • RSI
  • 62.38
  • MFI
  • 64.15

Latest Stock News Updates

This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is expanding its manufacturing capacity with a new facility in Khopoli, Maharashtra

US FDA Issues Warning Letter To Kilitch Healthcare For Navi-Mumbai Plant

The warning letter summarises significant violations of current good manufacturing practice regulations for finished pharmaceuticals at the Navi-Mumbai plant, which produces finished pharmaceuticals.

Kilitch Drugs Standalone December 2023 Net Sales at Rs 29.77 crore, up 4.43% Y-o-Y

Kilitch Drugs(I) Financials

Kilitch Drugs(I) Technicals

EMA & SMA

Current Price
₹189.03
+ 7.24 (3.98%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹176.10
  • 50 Day
  • ₹166.90
  • 100 Day
  • ₹165.00
  • 200 Day
  • ₹169.10

Resistance and Support

187.46 Pivot Speed
  • R3 203.81
  • R2 197.84
  • R1 193.43
  • S1 183.05
  • S2 177.08
  • S3 172.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kilitch Drugs India has an operating revenue of Rs. 235.47 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 16% is great, ROE of 10% is good. The company has a reasonable debt to equity of 21%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 7% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 61 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kilitch Drugs(I) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-15 Audited Results
2026-02-11 Quarterly Results & Bonus issue
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results
2025-07-02 Others Inter-alia, to consider 1. Fund Raising by way of issue of equity shares of face value of 10/-each through Rights Issue. 2. Deployment of the proceeds of the Right Issue. 3. Other business matters. issue of equity shares of Rs. 10/- in the ratio of 2:23 @ premium of Rs. 347/-.
Date Purpose Remarks
2026-03-24 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Kilitch Drugs(I) Shareholding Pattern

63.77%
0%
0%
0%
0%
29.7%
6.53%

Kilitch Drugs(I) FAQs

Kilitch Drugs(I) share price is ₹189 As on 12 June, 2026 | 23:52

The Market Cap of Kilitch Drugs(I) is ₹660.9 Cr As on 12 June, 2026 | 23:52

The P/E ratio of Kilitch Drugs(I) is 21.9 As on 12 June, 2026 | 23:52

The PB ratio of Kilitch Drugs(I) is 2.4 As on 12 June, 2026 | 23:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23